|
1
|
63
|
Male
|
Lt. Temporal GBM
|
2
|
Yes/Grade 2 skin reaction
|
|
2
|
60
|
Male
|
Lt. Temporal AA
|
3
|
Yes/Grade 1 skin reaction
|
|
3
|
40
|
Male
|
Rt. Frontal GBM
|
3
|
No due to tumor progression
|
|
4
|
57
|
Male
|
Lt. Parieto/Occi GBM
|
1
|
No due to tumor progression
|
|
5
|
32
|
Female
|
Lt. Parieto/Occi GBM
|
1
|
No due to tumor progression
|
|
6
|
53
|
Female
|
Rt. Frontal GBM
|
2
|
No due to tumor progression
|
|
99-111
| | | | | |
|
Case #
|
Age
|
Gender
|
Tumor
|
TTP (Months)
|
Vaccine/Adverse events
|
|
1
|
56
|
Male
|
Lt. Parietal GBM
|
4
|
Yes/Grade 1 headache
|
|
2
|
66
|
Male
|
Rt. Frontal GBM
|
N/A
|
No due to tumor progression
|
|
3
|
45
|
Male
|
Lt. Temporal GBM
|
10
|
Yes/None
|
|
4
|
53
|
Male
|
Lt. Occipital GBM
|
6
|
Yes/None
|
|
5
|
50
|
Male
|
Rt. Frontal GBM
|
6
|
Yes/None
|
|
6
|
61
|
Female
|
Rt. Temporal GBM
|
4
|
Yes/None
|
